Snowball logo
logo
DUL

ALNYLAM PHARMA (DUL.SG)

€203.50€0.00  (0%)
Estimate
P/E
38.5
EPS
5.29
Beta
0.675
Growth
Revenue, YoY
71.32%
Net income, YoY
333.83%
FCF, YoY
159.58%
About the company
Ticker
DUL
ISIN
US02043Q1076
Country
Other
Sector (GICS)
Materials
There is no Profile data available for DUL.SG.

Frequently asked questions

What sector does ALNYLAM PHARMA (DUL.SG) (DUL) operate in?

ALNYLAM PHARMA (DUL.SG) belongs to the Materials sector and operates in the Other industry.

What is ALNYLAM PHARMA (DUL.SG) (DUL) current stock price?

As of the latest data, ALNYLAM PHARMA (DUL.SG) stock price is €203.50, with a previous close of €203.50.

What is ALNYLAM PHARMA (DUL.SG) (DUL) Earnings Per Share (EPS)?

The trailing EPS is €5.29.

What is ALNYLAM PHARMA (DUL.SG) (DUL) Price-to-Earnings (P/E) ratio?

ALNYLAM PHARMA (DUL.SG) current P/E ratio is 38.47.

What is ALNYLAM PHARMA (DUL.SG) (DUL) EBITDA?

ALNYLAM PHARMA (DUL.SG) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 239.67 million.

Does ALNYLAM PHARMA (DUL.SG) (DUL) pay dividends?

No. ALNYLAM PHARMA (DUL.SG) does not pay a dividend.

When is ALNYLAM PHARMA (DUL.SG) (DUL) next earnings report?

ALNYLAM PHARMA (DUL.SG) is expected to release its next earnings report on September 30, 2026.

What is ALNYLAM PHARMA (DUL.SG) (DUL) beta (volatility) score?

ALNYLAM PHARMA (DUL.SG) has a beta of 0.675, indicating lower volatility than the overall market.